safinamide 50 MG Oral Tablet
- RxCUI
- 1922466
- RxNorm name
- safinamide 50 MG Oral Tablet
- Display name
- safinamide 50 MG Oral Tablet
- Full name
- safinamide 50 MG Oral Tablet
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:20
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Xadago | SAFINAMIDE MESYLATE | MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc. | c4d65f28-983f-42b4-bb23-023ae0fe81b2 | 2025-10-22 | Warnings, Adverse reactions | 1922466 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| c4d65f28-983f-42b4-bb23-023ae0fe81b2 | safinamide 50 MG Oral Tablet | SCD | 20 | These highlights do not include all the information needed to use XADAGO ® safely and effectively. See full prescribing information for XADAGO ® . XADAGO ® (safinamide) tablets, for oral use Initial U.S. Approval: 2017 | 20251022 |
| c4d65f28-983f-42b4-bb23-023ae0fe81b2 | safinamide 50 MG Oral Tablet | PSN | 20 | These highlights do not include all the information needed to use XADAGO ® safely and effectively. See full prescribing information for XADAGO ® . XADAGO ® (safinamide) tablets, for oral use Initial U.S. Approval: 2017 | 20251022 |
| c4d65f28-983f-42b4-bb23-023ae0fe81b2 | safinamide 50 MG (as safinamide mesylate 65.88 MG) Oral Tablet | SY | 20 | These highlights do not include all the information needed to use XADAGO ® safely and effectively. See full prescribing information for XADAGO ® . XADAGO ® (safinamide) tablets, for oral use Initial U.S. Approval: 2017 | 20251022 |